Otrivin (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin, is an alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin (xylometazoline hydrochloride) acts on nasal vasculature to reduce swelling and improve airflow.

- Common cold: provides temporary relief of nasal congestion. - Acute sinusitis: helps clear blocked nasal passages. - Allergic rhinitis: reduces nasal obstruction caused by allergens. - Nasal surgery recovery: assists in maintaining airway patency post‑operatively.

Adverse reactions to Otrivin are generally mild and reversible.

Common Side Effects: - Burning sensation in the nose. - Stinging or itching itching. - Nasal dryness. - Sneezing. - Headache.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Rebound congestion after prolonged use. - Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing. - Hypertension   

When  ​         …     … …  …   ...      … … … … … …  … …  t  …   … …  … … … ... """"  ​ "  … … … …